>
  1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Logos Global Management LP Buys Forma Therapeutics Holdings Inc, Keros Therapeutics Inc, Global Blood Therapeutics Inc, Sells Reata Pharmaceuticals Inc, BioNTech SE, Arena Pharmaceuticals Inc

Investment company Logos Global Management LP (Current Portfolio) buys Forma Therapeutics Holdings Inc, Keros Therapeutics Inc, Global Blood Therapeutics Inc, Sarepta Therapeutics Inc, Dyne Therapeutics Inc, sells Reata Pharmaceuticals Inc, BioNTech SE, Arena Pharmaceuticals Inc, Akebia Therapeutics Inc, Immunovant Inc during the 3-months ended 2020Q3, according to the most recent filings of the investment company, Logos Global Management LP. As of 2020Q3, Logos Global Management LP owns 34 stocks with a total value of $556 million. These are the details of the buys and sells.

For the details of Logos Global Management LP's stock buys and sells, go to https://www.gurufocus.com/guru/logos+global+management+lp/current-portfolio/portfolio

These are the top 5 holdings of Logos Global Management LP
  1. Keros Therapeutics Inc (KROS) - 1,600,000 shares, 11.09% of the total portfolio. Shares added by 300.00%
  2. Forma Therapeutics Holdings Inc (FMTX) - 1,173,188 shares, 10.51% of the total portfolio. New Position
  3. Global Blood Therapeutics Inc (GBT) - 850,000 shares, 8.43% of the total portfolio. Shares added by 529.63%
  4. TG Therapeutics Inc (TGTX) - 1,750,000 shares, 8.42% of the total portfolio. Shares added by 105.88%
  5. Sarepta Therapeutics Inc (SRPT) - 275,000 shares, 6.94% of the total portfolio. New Position
New Purchase: Forma Therapeutics Holdings Inc (FMTX)

Logos Global Management LP initiated holding in Forma Therapeutics Holdings Inc. The purchase prices were between $32.95 and $50.25, with an estimated average price of $40.52. The stock is now traded at around $38.32. The impact to a portfolio due to this purchase was 10.51%. The holding were 1,173,188 shares as of .

New Purchase: Sarepta Therapeutics Inc (SRPT)

Logos Global Management LP initiated holding in Sarepta Therapeutics Inc. The purchase prices were between $127.12 and $172.34, with an estimated average price of $151.84. The stock is now traded at around $132.71. The impact to a portfolio due to this purchase was 6.94%. The holding were 275,000 shares as of .

New Purchase: Dyne Therapeutics Inc (DYN)

Logos Global Management LP initiated holding in Dyne Therapeutics Inc. The purchase prices were between $20 and $23.9, with an estimated average price of $21.95. The stock is now traded at around $18.95. The impact to a portfolio due to this purchase was 5.82%. The holding were 1,604,392 shares as of .

New Purchase: Avidity Biosciences Inc (RNA)

Logos Global Management LP initiated holding in Avidity Biosciences Inc. The purchase prices were between $23.35 and $35.94, with an estimated average price of $28.87. The stock is now traded at around $28.40. The impact to a portfolio due to this purchase was 3.65%. The holding were 721,454 shares as of .

New Purchase: Athira Pharma Inc (ATHA)

Logos Global Management LP initiated holding in Athira Pharma Inc. The purchase prices were between $16.02 and $18.46, with an estimated average price of $16.7. The stock is now traded at around $24.51. The impact to a portfolio due to this purchase was 3.39%. The holding were 1,020,812 shares as of .

New Purchase: Compass Pathways PLC (CMPS)

Logos Global Management LP initiated holding in Compass Pathways PLC. The purchase prices were between $28.83 and $43.17, with an estimated average price of $35.95. The stock is now traded at around $34.29. The impact to a portfolio due to this purchase was 3.14%. The holding were 500,000 shares as of .

Added: Keros Therapeutics Inc (KROS)

Logos Global Management LP added to a holding in Keros Therapeutics Inc by 300.00%. The purchase prices were between $27.04 and $62.21, with an estimated average price of $39.74. The stock is now traded at around $68.57. The impact to a portfolio due to this purchase was 8.32%. The holding were 1,600,000 shares as of .

Added: Global Blood Therapeutics Inc (GBT)

Logos Global Management LP added to a holding in Global Blood Therapeutics Inc by 529.63%. The purchase prices were between $52.76 and $74.49, with an estimated average price of $63.55. The stock is now traded at around $42.62. The impact to a portfolio due to this purchase was 7.09%. The holding were 850,000 shares as of .

Added: TG Therapeutics Inc (TGTX)

Logos Global Management LP added to a holding in TG Therapeutics Inc by 105.88%. The purchase prices were between $18.49 and $27.24, with an estimated average price of $22.98. The stock is now traded at around $29.98. The impact to a portfolio due to this purchase was 4.33%. The holding were 1,750,000 shares as of .

Added: BioXcel Therapeutics Inc (BTAI)

Logos Global Management LP added to a holding in BioXcel Therapeutics Inc by 83.33%. The purchase prices were between $37.44 and $64.63, with an estimated average price of $46.92. The stock is now traded at around $49.37. The impact to a portfolio due to this purchase was 1.95%. The holding were 550,000 shares as of .

Added: Repare Therapeutics Inc (RPTX)

Logos Global Management LP added to a holding in Repare Therapeutics Inc by 46.48%. The purchase prices were between $21.55 and $33.92, with an estimated average price of $26.53. The stock is now traded at around $27.79. The impact to a portfolio due to this purchase was 1.71%. The holding were 976,894 shares as of .

Added: Calliditas Therapeutics AB (CALT)

Logos Global Management LP added to a holding in Calliditas Therapeutics AB by 83.33%. The purchase prices were between $21.61 and $25.69, with an estimated average price of $23.27. The stock is now traded at around $32.76. The impact to a portfolio due to this purchase was 1.08%. The holding were 550,000 shares as of .

Sold Out: Reata Pharmaceuticals Inc (RETA)

Logos Global Management LP sold out a holding in Reata Pharmaceuticals Inc. The sale prices were between $93.53 and $163.34, with an estimated average price of $125.03.

Sold Out: BioNTech SE (BNTX)

Logos Global Management LP sold out a holding in BioNTech SE. The sale prices were between $57.81 and $104.17, with an estimated average price of $71.42.

Sold Out: Arena Pharmaceuticals Inc (ARNA)

Logos Global Management LP sold out a holding in Arena Pharmaceuticals Inc. The sale prices were between $60.76 and $75.83, with an estimated average price of $66.59.

Sold Out: Akebia Therapeutics Inc (AKBA)

Logos Global Management LP sold out a holding in Akebia Therapeutics Inc. The sale prices were between $2.39 and $13.08, with an estimated average price of $8.75.

Sold Out: Immunovant Inc (IMVT)

Logos Global Management LP sold out a holding in Immunovant Inc. The sale prices were between $22.61 and $38.9, with an estimated average price of $30.07.

Sold Out: Zogenix Inc (ZGNX)

Logos Global Management LP sold out a holding in Zogenix Inc. The sale prices were between $17.5 and $29.36, with an estimated average price of $24.56.



Here is the complete portfolio of Logos Global Management LP. Also check out:

1. Logos Global Management LP's Undervalued Stocks
2. Logos Global Management LP's Top Growth Companies, and
3. Logos Global Management LP's High Yield stocks
4. Stocks that Logos Global Management LP keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
wigbertHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)